Skip to main content
SpringerLink
Log in

Infection Control to Reduce Invasive Fungal Infections

  • Chapter
  • First Online:
Clinically Relevant Mycoses

  • 699 Accesses

Abstract

Substantial progress in diagnostic and therapeutic medical procedures over the past century has helped increase longevity in the industrialized world. Progress in oncological treatment options, successful human organ as well as hematopoietic stem cell transplantation can be counted as some of the biggest achievements of modern medicine. With the development of more effective immunosuppressive drugs, organ transplants have become an accepted treatment for a growing number of otherwise incurable diseases. Longer survival of transplant recipients has at the same time greatly increased the number of immunocompromised patients. These patients are typically at greater risk of acquiring infections caused by the so-called opportunistic organisms such as fungi, whose virulence is low in immunocompetent patients. The types of fungal infection occurring in susceptible patients depend not only on the host’s underlying disease, i.e. their net state of immuno-suppression but also on their epidemiological exposure and/or colonization with opportunistic fungi. The prevention of endogenous as well as exogenous invasive fungal infections in susceptible patient groups therefore necessitates a combination of antifungal stewardship with environmental infection control strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554

    Article  Google Scholar 

  2. Dasbach EJ, Davies GM, Teutsch SM (2000) Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 31:1524–1528

    Article  CAS  Google Scholar 

  3. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177

    Article  Google Scholar 

  4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309–317

    Article  Google Scholar 

  5. Brandt ME, Warnock DW (2003) Laboratory aspects of medical mycology. In: Dismukes WE, Pappas PG, Sobel JD (eds) Clinical mycology. Oxford University Press, New York, pp 1–22

    Google Scholar 

  6. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS (2013) Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10–24

    Article  CAS  Google Scholar 

  7. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20(1):133–163

    Article  CAS  Google Scholar 

  8. Cantón E, Espinel-Ingroff A, Peman J, del Castillo L (2010) In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob Agents Chemother 54:2194–2197

    Article  Google Scholar 

  9. Valerio M, Rodriguez-Gonzalez CG, Muñoz P, Caliz B, Sanjurjo M, Bouza E, COMIC Study Group (Collaborative Group on Mycoses) (2014) Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed. J Antimicrob Chemother 69(7):1993–1999

    Article  CAS  Google Scholar 

  10. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 50(8):1091–1100

    Article  Google Scholar 

  11. Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26(4):781–803

    Article  CAS  Google Scholar 

  12. Bouza E, Peláez T, Pérez-Molina J, Marín M, Alcalá L, Padilla B, Muñoz P, Adán P, Bové B, Bueno MJ, Grande F, Puente D, Rodríguez MP, Rodríguez-Créixems M, Vigil D, Cuevas O, Team AS (2002) Demolition of a hospital building by controlled explosion: the impact on filamentous fungal load in internal and external air. J Hosp Infect 52(4):234–242

    Article  CAS  Google Scholar 

  13. Burwen DR, Lasker BA, Rao N, Durry E, Padhye AA, Jarvis WR (2001) Invasive aspergillosis outbreak on a hematology-oncology ward. Infect Control Hosp Epidemiol 22(1):45–48

    Article  CAS  Google Scholar 

  14. Vonberg RP, Gastmeier P (2006) Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63(3):246–254

    Article  Google Scholar 

  15. Srinivasan A, Beck C, Buckley T, Geyh A, Bova G, Merz W, Perl TM (2002) The ability of hospital ventilation systems to filter Aspergillus and other fungi following a building implosion. Infect Control Hosp Epidemiol 23(9):520–524

    Article  Google Scholar 

  16. Berger J, Willinger B, Diab-Elschahawi M, Blacky A, Kalhs P, Koller W, Assadian O, Aichberger KJC et al (2011) Effectiveness of preventive measures for hemato-oncologic patients undergoing stem cell transplantation during a period of hospital construction. Am J Infect Control 39(9):746–751

    Article  Google Scholar 

  17. Anderson K, Morris G, Kennedy H, Croall J, Michie J, Richardson MD, Gibson B (1996) Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 51(3):256–261

    Article  CAS  Google Scholar 

  18. Ruutu P, Valtonen V, Tiitanen L, Elonen E, Volin L, Veijalainen P, Ruutu T (1987) An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis 19(3):347–351

    Article  CAS  Google Scholar 

  19. Chang CC, Ananda-Rajah M, Belcastro A, McMullan B, Reid A, Dempsey K, Athan E, Cheng AC, Slavin MA (2014) Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 44(12b):1389–1397

    Article  CAS  Google Scholar 

  20. Sehulster L, Chinn RYW, Arduino MJ, Carpenter J, Donlan R, Ashford D et al (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). American Society for Healthcare Engineering/American Hospital Association, Chicago

    Google Scholar 

  21. Department of Health Estates and Facilities (UK) (2013) Health building note 00-09: infection control in the built environment UK. Department of Health, London

    Google Scholar 

  22. National Disease Surveillance Centre (Ireland) (2002) National guidelines for the prevention of nosocomial invasive aspergillus during construction/renovation activities. NDSC, Dublin

    Google Scholar 

  23. Morris G, Kokki MH, Anderson K, Richardson MD (2000) Sampling of aspergillus spores in air. J Hosp Infect 44(2):81–92

    Article  CAS  Google Scholar 

  24. Roilides E (2016) Emerging fungi causing human infection: new or better identified? Clin Microbiol Infect 22(8):660–661

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Vienna, Austria

    Magda Diab-El Schahawi

Authors
  1. Magda Diab-El Schahawi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magda Diab-El Schahawi .

Editor information

Editors and Affiliations

  1. Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Wien, Austria

    Elisabeth Presterl

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schahawi, M.DE. (2019). Infection Control to Reduce Invasive Fungal Infections. In: Presterl, E. (eds) Clinically Relevant Mycoses. Springer, Cham. https://doi.org/10.1007/978-3-319-92300-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92300-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92299-7

  • Online ISBN: 978-3-319-92300-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation